ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,434, issued on July 14.

"Compositions and methods for modulating ACE2 receptor" was invented by Kamal Khan Mubarak (Ann Arbor, Mich.) and Eman Azra Mubarak (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in certain embodiments are compositions and methods for treating coronavirus related adverse events with an angiotensin-converting enzyme 2 (ACE2) receptor modulator."

The patent was filed on April 12, 2021, under Application No. 17/917,984.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.h...